In a 12 week observational study of everyday clinical practice, Harmer et al. have shown that once daily insulin glargine plus OADs is an effective therapeutic regimen with a good safety profile for patients with T2DM who were inadequately controlled with premixed insulin [5]. This evidence concerns the gene INS and type 2 diabetes mellitus.